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ABSTRACT 
 During ribosomal RNA (rRNA) maturation, cleavages at defined sites separate the mature 
rRNAs from spacer regions, but the identities of several enzymes required for 18S rRNA 
release remain unknown. PilT N-terminus (PIN) domain proteins are frequently 
endonucleases and the PIN domain protein Utp24 is essential for early cleavages at three 
pre-rRNA sites in yeast (A0, A1 and A2) and humans (A0, 1 and 2a). In yeast, A1 is cleaved 
prior to A2 and both cleavages require base-pairing by the U3 snoRNA to the central 
pseudoknot elements of the 18S rRNA. We found that yeast Utp24 UV-crosslinked in vivo to 
U3 and the pseudoknot, placing Utp24 close to cleavage at site A1. Yeast and human Utp24 
proteins exhibited in vitro endonuclease activity on an RNA substrate containing yeast site 
A2. Moreover, an intact PIN domain in human UTP24 was required for accurate cleavages 
at sites 1 and 2a in vivo, whereas mutation of another potential site 2a endonuclease, RCL1, 
did not affect 18S production. We propose that Utp24 cleaves sites A1/1 and A2/2a in yeast 
and human cells. 
Keywords: endonuclease cleavage/PIN domain/ribosome biogenesis/RNA cyclase 
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INTRODUCTION 
 The eukaryotic rRNAs are processed from the 35S (Saccharomyces cerevisiae) or 47S 
(Homo sapiens) rRNA precursors (pre-rRNAs) by initial endonucleolytic cleavages and 
subsequent exonucleolytic trimming, with concomitant removal of external (5’-ETS, 3’-ETS) 
and internal (ITS1, ITS2) transcribed spacer sequences (Figures 1 and S1) (reviewed in (1)). 
 Early pre-rRNA cleavages, at sites called A0, A1 and A2 in yeast and A0, A1/1 and 2a/E 
in humans, are important for 18S rRNA maturation. These events require a large 
ribonucleoprotein complex, the small subunit (SSU) processome (or 90S pre-ribosome) 
(reviewed in (2)). A key component of the SSU processome is the U3 small nucleolar 
(sno)RNA, which base-pairs with the 5’-ETS and 18S rRNA elements to chaperone the 
formation of the conserved pseudoknot, a key structural feature of the 40S ribosomal subunit 
(reviewed in (2,3)). 
 Loss of many different SSU processome components blocks pre-rRNA cleavage at sites 
A0, A1/1 and A2/2a, making it unclear which factor is the active nuclease. However, two 
evolutionarily conserved factors feature protein domains linked to RNA processing. Yeast 
Utp24/Fcf1 and human UTP24 harbor PIN (PilT N-terminus) endonuclease domains (4), 
whereas yeast Rcl1 and human RCL1 exhibit RNA cyclase-like protein folds (5). A PIN 
domain is also found in the endonuclease Nob1, which catalyzes the final cytoplasmic 
maturation step at the 3’-end of the 18S rRNA (site D) in yeast (6-8). 
 Yeast Utp24 and Rcl1 are essential for growth and conditional depletion of either protein 
inhibits A0, A1 and A2 cleavage (4,5,9). However, mutation of the PIN domain of Utp24 
specifically inhibited cleavage at sites A1 and A2, while cleavage at site A0 was unaffected 
(4), and the mutant was dominant negative when expressed together with intact Utp24. 
These observations suggested that the presence of Utp24 is required for SSU processome 
function in A0-A2 cleavage, whereas the PIN domain harbors the catalytic activity for A1 and 
A2 cleavage (4), but nuclease activity was not demonstrated. Mutation of Rcl1 also inhibited 
site A2 cleavage, with less effect at A0 and A1 (5,9,10), and recombinant Rcl1 was reported 
to cleave pre-rRNA transcripts containing yeast site A2, consistent with direct endonuclease 
activity (9). 
 In mammals, the equivalent pre-rRNA cleavages also require the presence of UTP24 
(FCF1 in mouse) and RCL1 (11-14) and the putative catalytic activity of human UTP24 was 
very recently linked to site 1 cleavage (15). However, the catalytic roles of UTP24 and RCL1 
with respect to 2a cleavage have not been established. 
 In yeast, mutational and kinetic analyses indicate that processing at sites A1 and A2 is 
tightly coupled and mainly co-transcriptional (16,17). In vertebrates, pre-rRNA processing 
appears to be largely posttranscriptional and A′ processing near the 5’-end of the 5’-ETS in 
humans, a cleavage site not present in yeast, appears to be the only co-transcriptional event 
(18). Cleavage at site 2a within the human ITS1 (equivalent to yeast A2) is part of a minor 
pathway in humans (Figure S1) (11,12,19). However, no precursors processed at site 2a but 
still containing 5’-ETS sequences are detected, indicating that A0, 1 and 2a cleavages are 
coupled within the SSU processome, as in yeast. 
 Here, we present a combination of in vivo and in vitro approaches to clarify the roles of 
Utp24 and Rcl1 in yeast and human ribosome biogenesis. In vivo RNA-protein crosslinking 
studies (CRAC) generated a transcriptome-wide RNA binding profile for yeast Utp24, which 
provides fresh insights into its function. We also performed in vitro assays using recombinant 
wild type and mutant Utp24 and Rcl1 proteins to assess their cleavage activity on pre-
ribosomal RNA. Finally, we established RNAi-rescue systems in HEK293 cells to study the 
effect of presumably catalytically inactive UTP24 and RCL1 mutants on pre-rRNA cleavage 
in the human system. 
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MATERIALS AND METHODS 
Yeast strains and methods 
 S. cerevisiae strains (Table S1) were constructed by standard methods (20). Cultures 
were grown at 30°C in medium containing 0.67% nitrogen base (Difco) and 2% glucose or 
2% galactose. Strains for crosslinking studies expressed genomically encoded, C-terminal 
HTP-tagged proteins under the control of their endogenous promoter. 
CRAC and data analysis 
 The CRAC method was performed as previously described (21) (22), see Figure S2A. To 
generate RNA-protein crosslinks, actively growing yeast cultures in SD medium (OD600 ~0.5) 
were UV-irradiated in a 1.2 m metal tube for 100 sec at 254 nm (22). Illumina sequencing 
data was aligned to the yeast genome using Novoalign (http://www.novocraft.com). 
Bioinformatics analyses were performed as described (23). The Illumina sequencing data 
from this publication have been submitted to the GEO database 
(http://www.ncbi.nlm.nih.gov/geo/) and assigned the identifier GSE75991. 
Cloning and mutagenesis 
 The open reading frames for Rcl1, Bms1, Utp24 or UTP24 were amplified from yeast 
genomic DNA or human cDNA adding restriction sites (Table S2) and cloned into pET100 
vectors (Invitrogen). The constructs were used for in vitro translation in the presence of [35S] 
methionine (TNT, Promega) or subcloned into pGEX-6P1 vectors to express and purify 
GST-tagged recombinant proteins from E.coli using standard techniques. The C-terminally 
HTP-tagged Rcl1 gene was amplified by PCR from yeast genomic DNA (Strain Rcl1-HTP) 
adding restriction sites to the 5’-end of the gene and the 3’-end of the HTP-tag, respectively, 
and cloned into pRS316. The coding sequences of UTP24 and RCL1 were altered to make 
them resistant to the siRNAs (Table S3) used to deplete the endogenous mRNAs. These 
constructs (IDT) were amplified by PCR and cloned into the pcDNA5/FRT/TO vector 
(Invitrogen) containing 2x N-terminal FLAG tags under the control of a tetracycline-inducible 
promoter. Point mutations were generated by QuikChange site-directed mutagenesis using 
overlapping primers (Table S2) and verified by sequencing. 
Cell Culture and RNAi 
 Constructs were transfected into Flp-In T-Rex HEK293 cells. Stably transfected cells 
were selected as described by the manufacturor (Invitrogen) and cultured according to 
standard protocols. Expression of exogenous proteins was induced by addition of 
tetracycline (UTP24; 1 mg/ml, RCL1; 0.01-0.1 mg/ml). Cells were transfected with siRNA 
duplexes (Table S3) using Lipofectamine RNAiMAX transfection reagent (Invitrogen) and 
harvested after 72h depletion. 
RNA analysis 
 RNA was extracted from HEK293 cell pellets using TRI reagent (Sigma-Aldrich). For 
northern blot analysis, 2 µg of total RNA was separated on 1.2% glyoxal-agarose gels, 
transferred to nylon membrane and hybridized with 5’-end labeled oligonucleotide probes 
(Table S2). For primer extension analysis, 1 µg of total RNA was converted into cDNA using 
Superscript III (Invitrogen) and 5’-end labeled oligonucleotide probes and separated on 10% 
PAA/8M urea sequencing gels. Results were visualized using a PhosphorImager (Typhoon 
FLA9000; GE Healthcare). ImageQuant (GE Healthcare) was used to quantify northern blot 
data, which were normalized to levels of the 47S/45S pre-rRNAs. 
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In vitro RNA cleavage assay 
 Recombinant proteins were expressed and purified as described in (24), including 1 mM 
MnCl2 in all media and buffers. Nuclease assays were performed in 10 mM Tris/HCl pH 7.6, 
100 mM NaCl, 2 mM dithiothreitol, 100 µg ml-1 bovine serum albumin, 0.8 unit µl-1 RNasin, 
4.5% glycerol, 0.05% Tween20, 10 ng µl-1 E.coli tRNA and 5 mM MnCl2. 10 µl reactions 
containing ~20 pmol of protein were pre-incubated for 5 min at 30°C. The only exception 
was for the experiment shown in Figure S4, for which detailed conditions are described in 
the supplementary figure legend S4. In vitro transcribed pre-rRNA substrates (0.125 pmol) 
containing yeast sites D and A2 (35S+2301-2844) or yeast sites A0 and A1 (35S+335-1146) 
was added and incubated for 1h at 30°C. Following proteinase K digestion (30 min at 37°C), 
the RNA was extracted, precipitated and analyzed by primer extension using probes yD-RT, 
yA2-RT or yA1-RT, respectively. Products were resolved on 10% PAA/8M urea sequencing 
gels and visualized by autoradiography. 
Protein-protein interaction studies and purification of Rcl1-containing complexes 
 GST-bait proteins (~50 pmol) were immobilized on glutathione sepharose and incubated 
with [35S] in vitro translates for 1h at 4°C in Buffer NB (20 mM Tris/HCl pH 7.6, 150 mM 
NaCl, 8.7% glycerol and 0.1% Tween20). The beads were washed five times with buffer NB. 
Retained proteins were separated by SDS-PAGE and visualized by autoradiography. 
Affinity-purification of Rcl1-HTP complexes (from 500 ml of yeast culture each) was 
performed essentially as described in (25). Complexes were purified on IgG sepharose at 
150 mM NaCl and eluted by TEV protease cleavage. Co-purifying proteins and RNAs were 
analyzed by immunoblotting or northern blotting, respectively (Tables S4 and S2). 
Yeast Immunofluorescence 
 Yeast strains expressing HA-tagged Rcl1 under control of the repressible GAL10 
promoter were transformed with plasmids encoding His6-TEV-protein A (HTP) tagged forms 
of Rcl1 and Rcl1RDK and grown in minimal medium containing glucose for 6h to deplete the 
endogenous protein. Cells at mid-log phase were harvested and fixed in 4% formaldehyde in 
PBS (15 min at RT), washed with PBS and then incubated for 45 min at 30°C in buffer B (0.1 
M potassium phosphate pH 7.5, 1 M sorbitol, 10 mM DTT) containing 50 U/ml Zymolase. 
Cells were washed and incubated in batch with the antibodies diluted in PBS + 5% milk 
(Table S4), washed with PBS containing DAPI (4’,6’-diamidino-2-phenylindole) and mounted 
onto poly-lysine coated coverslips using Vectorshield. All images were obtained using a 
Zeiss Axiovert 200 microscope with Plan-Apochromat x100 1.4NA objective, Axiovision 
software and an Axiocam monochrome camera, and processed in Photoshop (Adobe). 
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RESULTS 
Yeast Utp24 crosslinks in close vicinity to site A1, to the U3 snoRNA and pre-rRNA 
elements required for pseudoknot formation 
 To dissect the roles of the two yeast candidate pre-rRNA endonucleases Rcl1 and Utp24, 
we applied in vivo RNA-protein crosslinking (CRAC) to identify their RNA binding sites (21) 
(Figures 1 and S2). C-terminal HTP-tagged (His6-TEV-protA) Rcl1 and Utp24 were 
expressed from the chromosomal locus under control of the endogenous promoter. Rcl1-
HTP supported wild-type growth, while the Utp24-HTP strain exhibited a mild growth defect. 
Actively growing cells were UV-irradiated as described (22) and RNA fragments crosslinked 
to the purified proteins were isolated and analyzed as outlined in Figure S2A. Protein 
recovery was verified by western analysis (Figure S2B). Rcl1 purified well, but crosslinked 
poorly, and no pre-rRNA target sequence was significantly enriched in every experiment. We 
were, however, able to reproducibly identify Utp24 RNA crosslinking sites in four 
independent CRAC experiments. Results from two representative datasets are presented in 
Figures 1 and S2. 
 Transcriptome-wide RNA binding profiles of Utp24 are shown in Figure 1A. The majority 
of reads (> 83%) identified in both Utp24 datasets were mapped to the (pre-)rRNA, with 
lower numbers of hits in snoRNAs. Hits were also recovered in mRNAs, but no individual 
mRNA emerged as a likely Utp24 target. Consistent with its known role in SSU biogenesis, 
Utp24 was predominately associated with sequences within the 18S rRNA (Figures 1B and 
C). Importantly, this crosslinking profile was not seen in a CRAC experiment performed with 
an untagged control strain (Figure 1B). The peak near the 3’-end of the 25S rRNA 
represents a common CRAC contaminant (21). 
 In CRAC, microdeletions and/or mutations are often introduced at the site of crosslinking 
during cDNA preparation and can be used to map precise protein-binding sites (26). Sites of 
microdeletion (Figures 1C and D) were seen at 18S+3, adjacent to cleavage site A1 (peak 3, 
see Figure S2C for higher resolution), around 18S+545 (peak 4) and around 18S+820 and 
18S+895 within expansion segment 6 (ES6) (peak 5), close to the binding site for the 
snoRNA snR30, which is also required for cleavage at sites A0-A2 (27). The highest peak 
was located at 18S+1103 in the vicinity of the 3’-side of the central pseudoknot (peak 6). 
Sites of microdeletion were also identified in the flanking 5’-ETS (Figure 1E) around 
35S+288 (peak 1) and 35S+460 (peak 2). Strikingly, these positions in the 5’-ETS 
correspond to the base-pairing sites for the U3 snoRNA 3’-hinge and 5’-hinge regions, 
respectively (reviewed in (3)). 
 Analysis of snoRNAs crosslinked to Utp24 (Figure 1F) revealed specific enrichment for 
the U3 snoRNA (encoded by the genes SNR17A/B). Utp24 predominately crosslinked to a 
U3 region (+15-90), which undergoes multiple interactions with the pre-rRNA. Significant 
peaks of microdeletions in U3 (Figures 1G and 1H) were seen at +45 and +52 (peaks b, 5’-
hinge) and +68 (peak c, 3’-hinge) that base-pair to 5’-ETS regions at +480 and +280, 
respectively (reviewed in (2,3)). The highest peak of microdeletions (peak a) was at +24, a 
region of U3 predicted to base-pair with 18S+1140 on the 3’-side of the pseudoknot. 
 We conclude that Utp24 binds both to the U3 snoRNA and to the corresponding U3-
binding sequences in the mature 18S rRNA and the 5’-ETS, interactions that are essential 
for pseudoknot formation and coupled cleavage of sites A0, A1 and A2. Moreover, the 
binding of Utp24 at 18S+3 is consistent with a direct role in cleavage at site A1, since the 
precise location of cleavage is partly defined with respect to this position (28). 
Utp24 cleaves site A2 in a yeast pre-rRNA substrate in vitro 
 The predicted catalytic center within the Utp24 PIN domain is characterized by four acidic 
residues (DEDD), which are conserved in all kingdoms of life (29). We therefore assessed 
the in vitro activities of yeast Utp24 and human UTP24 in cleavage assays (Figures 2, S3 
and S4). Wild type and PIN domain mutant proteins were expressed in E. coli with N-
terminal tags containing GST. Double (D72N/D142N) catalytic site mutations in UTP24 were 
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based on yeast Utp24 mutations (D68N, D138N) that cause A1 and A2 cleavage defects in 
vivo (4). The N-terminal GST tag was removed by prescission protease (PP) cleavage 
following purification (Figure S3A). 
 The proteins were tested in nuclease assays on in vitro transcribed RNA containing yeast 
site A2 (Figure 2A) or A1 (Figure S3B). Assays were performed in the presence of 5 mM 
Mn2+, which is required for the in vitro activity of other PIN domain nucleases (7,25,30). The 
RNA was analyzed by primer extension using a labeled oligonucleotide downstream of the 
cleavage site. 
 Wild type yeast and human Utp24 both cleaved the RNA substrate containing site A2, 
giving very similar products (Figure 2B, lanes 8 and 12). In contrast, no cleavage activity was 
observed for the predicted catalytically inactive Utp24 PIN mutants (Figure 2B, lanes 9, 10 
and 13), while a different PIN domain endonuclease, Nob1, cleaved site D but not A2 (Figure 
S3D). Utp24-mediated cleavage did not occur exclusively at site A2, but also at several other 
places with the same sequence context (5’C/A3’, where “/” equals the site of cleavage) 
around the bona fide cleavage site. In contrast, we did not detect clear cleavage at site A1 
(Figure S3B, see Discussion). An evolutionarily conserved ACAC motif at site A2 was 
previously identified as a specificity feature for yeast A2 cleavage in vivo (31). Since the in 
vitro cleavage pattern was identical for yeast and human Utp24 in our assays, this appears 
to be a conserved feature of Utp24 PIN nuclease activity. 
Yeast Rcl1 was also expressed and purified with a cleavable GST-PP tag (Figures 2 and 
S3A), but no in vitro cleavage activity was detected in the presence of 5 mM Mn2+ (Figure 
2B, lane 11). In an effort to reproduce the reported nuclease activity of Rcl1 (9), we dialyzed 
the yeast Rcl1 protein, as well as wild type and mutant Utp24 proteins, into the buffer 
optimized for Rcl1 activity (K. Karbstein, personal communication) and performed the 
nuclease assay in the presence of 10 mM Mg2+ Under these conditions, apparent cleavage 
at site A2 was observed (Figure S4), as reported. However, cleavage was observed with 
each of the recombinant proteins, including the catalytically inactive Utp24D68N mutant, 
indicating that cleavage associated with addition of Utp24 was not specific. We were unable 
to express and purify a mutant of Rcl1 that is predicted to lack catalytic activity, and were 
therefore unable to determine whether this is also the case for Rcl1. 
An intact PIN domain in human UTP24 is required for accurate cleavages at sites 1 
and 2a, but not A0, in vivo 
 Yeast cleavage sites A0-A2 have direct counterparts in humans called sites A0, 1 and 2a 
(Figure S1). RNAi-mediated knockdown of human UTP24 caused 30S pre-rRNA 
accumulation, indicating that UTP24 is required for these cleavages (11,13). To investigate 
the putative catalytic role of UTP24, we established an RNAi-rescue system in HEK293 
cells. Cells stably expressing the FLAG-tag (pcDNA5) or FLAG-tagged forms of either wild 
type UTP24, or UTP24 with single (D72N) or double (D72N/D142N) catalytic site mutations 
were generated (Figures 3 and S5). These carried silent mutations in the open reading 
frames rendering them resistant to RNAi-mediated depletion of the endogenous protein. The 
RNAi-resistant proteins were expressed at endogenous levels using a titratable TET 
promoter. Cells were transfected with either a siRNA specifically targeting endogenous 
UTP24 or a control siRNA targeting firefly luciferase (GL2) (32). After siRNA treatment for 
72h, the expression of endogenous and FLAG-tagged UTP24 proteins was analyzed by 
immunoblotting (Figure S5A). The UTP24-specific siRNA significantly reduced endogenous 
protein levels, whereas the RNAi-resistant tagged UTP24 proteins were unaffected. 
 Total RNA was extracted from RNAi-treated cells and pre-rRNA processing analyzed by 
northern hybridization using probes complementary to the 5’-end of ITS1 (“h18SE”) or 
downstream of the 2a cleavage site (“hITS1”) (Figure 3B and S5B). Depletion of UTP24 
resulted in 30S accumulation (Figure 3B, lane 2), and this phenotype was almost completely 
rescued by expression of the wild type protein (lane 4). Complementation with UTP24 D72N 
or D72N/D142N mutants caused accumulation of the 26S pre-rRNA (lanes 6 and 8), 
indicative of strongly reduced cleavage at sites 1 and 2a. No dominant negative phenotypes 
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were observed upon expression of the PIN mutants in the presence of the endogenous 
protein (lanes 5 and 7). 
 The 26S RNA accumulation indicated that the catalytic activity of human UTP24 is 
required for site 1 and 2a cleavage in vivo, while cleavage at site A0 is unaffected. However, 
2a cleavage cannot readily be directly assessed because the 36S pre-rRNA and the excised 
ITS1 fragment, the only intermediates specific to the “minor” pathway (lighter shades in 
Figure 3A), are barely detectable in control cells. However, depletion of the 5’-3’-
exonuclease XRN2 stimulates processing through this pathway (11,19,33). We therefore 
performed UTP24 knockdown and complementation in combination with XRN2 depletion. 
Pre-rRNA intermediates were detected by northern hybridization with probe hITS1 (Figure 
3C), and quantified using a PhosphorImager. Levels were normalized to the 47S/45S pre-
rRNA and plotted to compare the single XRN2 and UTP24/XRN2 double knockdowns 
(Figure 3D). Depletion of XRN2 alone caused strong accumulation of the 36S pre-rRNA and 
the ITS1 fragment accompanied by the appearance of the 30SL5’ precursor (also referred to 
as 34S (12) (Figure 3C, lanes 1, 3, 5 and 7), reflecting an A’ cleavage defect. Double-
knockdown of UTP24 and XRN2 (lane 2) resulted in a strong decrease in the 36S precursor 
and the ITS1 fragment compared to the single XRN2 knockdown, while expression of the 
wild type UTP24 protein rescued the 2a processing defect (lane 4). Importantly, the 36S pre-
rRNA and the excised ITS1 fragment were also severely reduced in double knockdown cells 
expressing UTP24 D72N (lane 6) or UTP24 D72N/D142N (lane 8), whereas 26S pre-rRNA 
levels were strongly increased. 
 Low levels of the 21S precursor were detected in UTP24 PIN mutant cells, suggesting 
that an alternative mechanism can generate the 18S rRNA 5’-end (site 1) in the absence of 
endonuclease cleavage. XRN2 degrades the 3’-fragment of the 5’-ETS (“ETS3”) (13) and 
might also digest the 5’-ETS back to site 1 following A0 cleavage. To test this model, RNA 
was extracted from cells expressing UTP24 D72N, treated with a siRNA against endogenous 
UTP24, XRN2 or both, and analyzed by primer extension through site 1 (Figure 3E). The 
major stop at site 1 reflects mature 18S rRNA produced prior to the siRNA treatment. In cells 
treated with the UTP24 siRNA (lane 7), a weaker primer extension stop was visible two 
nucleotides downstream of site 1. This was significantly reduced in the UTP24/XRN2 double 
knockdown (lane 9) and absent when the catalytically inactive UTP24 was not expressed 
(Figure S5C). We speculate that in the absence of site 1 cleavage, XRN2 degrades the 5’-
ETS region, but can be blocked by catalytically inactive UTP24 bound at the 5’-end of 18S, 
leading to the observed truncated product. 
 Our analyses indicate that point mutations in the PIN domain of UTP24 block cleavage at 
sites 1 and 2a in human pre-rRNA, while cleavages at sites A0 and A’ are unaffected. 
Mutation of the proposed pre-rRNA substrate binding site within human RCL1 does 
not affect 18S production or 2a cleavage 
 Yeast Rcl1 was also reported to cleave at site A2 (9), suggesting the possibility of 
redundant activities. To determine whether RCL1 participates in human site 2a cleavage, we 
established an RCL1 RNAi-rescue system in HEK293 cells, as described for UTP24 (Figures 
4 and S6). Endogenous and FLAG-tagged RCL1 levels were monitored by immunoblotting 
(Figure S6A). RNAi-mediated depletion of RCL1 caused 30S accumulation (Figure 4A, lane 
2), that was rescued by expression of RNAi-resistant FLAG-tagged wild type RCL1 (Figure 
4A, lane 4). 
 In yeast Rcl1 an “RDK-AAA” mutant showed a strong A2 cleavage defect, which was 
proposed to be due to impaired pre-rRNA substrate binding (9). A stable cell line was 
constructed expressing RCL1 with the equivalent “RHK” residues (R329, H330, K332) 
changed to alanines. Following RCL1 depletion, RCL1RHK-AAA fully rescued the 30S 
phenotype, showing that integrity of the proposed RNA substrate-binding pocket is not 
required for human 18S maturation (Figure 4A, lane 6). 
 As noted above, XRN2 knockdown increases dependency on 2a cleavage, so the RCL1 
knockdowns were repeated in combination with XRN2 depletion (Figure 4B). Following 
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RNAi-mediated knockdown of XRN2 and RCL1, wild type RCL1 and the RCL1RHK mutant 
again rescued the pre-rRNA processing phenotype to a similar extent (Figure 4B, lanes 4 
and 6). Quantification of pre-rRNA levels normalized to the 47S/45S pre-rRNAs confirmed 
that the 2a-dependent pre-rRNA intermediates, the 36S pre-RNA and the ITS1 fragment, are 
restored to similar levels in cells expressing wild type and mutant RCL1, but severely 
reduced in cells expressing the FLAG-tag only (Figure 4C). 
Yeast Rcl1 mutations impair interactions with Bms1, integration into the SSU 
processome and subcellular localization 
 The finding that the human equivalent of the yeast Rcl1RDK mutant supports pre-rRNA 
processing prompted us to re-examine the ribosome synthesis defect in yeast (Figure 5). 
Recent mutational analysis of Rcl1 based on the crystal structure of the yeast Rcl1-Bms1 
dimer showed that mutation of R237, within the RDK motif, disrupts interaction with Bms1 
(10). The Rcl1-Bms1 interaction is required for nuclear import of Rcl1 (34) and, consistent 
with this, an R237A mutation severely impaired the nucleolar localization of yeast Rcl1 (10). 
 Wild type Rcl1 and Rcl1RDK were generated by in vitro translation in the presence of [
35S] 
methionine. Incubation with recombinant GST-tagged Bms1(aa1-705) (Figure 5A) revealed a 
strong and reproducible interaction between the N-terminal region of Bms1 and the wild type 
Rcl1 protein, whereas no binding was detected for the Rcl1RDK mutant. 
 This finding suggested that Rcl1RDK might not be incorporated into the SSU processome 
in vivo. To test this, we generated a yeast strain expressing HA-tagged Rcl1 under control of 
the repressible GAL10 promoter, allowing depletion of the endogenous Rcl1 protein. This 
strain was then transformed with plasmids encoding His6-TEV-protein A (HTP) tagged forms 
of Rcl1 and Rcl1RDK, or an empty plasmid (pRS316) and grown in minimal medium 
containing glucose. Rcl1-containing complexes were purified on IgG sepharose followed by 
TEV cleavage, and associated proteins and RNA were detected by western and northern 
blotting, respectively (Figure 5). This revealed that Rcl1 and Rcl1RDK were expressed and 
purified to similar levels. However, association of Rcl1RDK with the boxC/D snoRNP-specific 
protein Nop1 (Figure 5B) as well as the U3 snoRNA and several pre-rRNA processing 
intermediates (23S, 22S/21S, 20S) (Figure 5C) was severely reduced, confirming that the 
Rcl1RDK mutant fails to associate with the SSU processome. To support this finding, we 
performed immunofluorescence in cells expressing HTP-tagged Rcl1 and Rcl1RDK (Figure 
5D). Wild type Rcl1 localized to the nucleolus as expected, whereas Rcl1RDK was mainly 
retained in the cytoplasm. 
 We conclude that pre-rRNA processing defects associated with yeast Rcl1RDK are likely 
due to impaired nuclear import and SSU processome formation, due to the loss of binding 
and recruitment via Bms1.  
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DISCUSSION 
 Here, we present data implicating Utp24 as the endonuclease responsible for early pre-
rRNA cleavages at sites A1/1 and A2/2a that generate the major precursor to the 18S rRNA. 
 In vivo UV crosslinking was performed in actively growing cells to identify bona fide RNA 
targets for yeast Utp24 (Figures 1 and S2). Utp24 RNA binding was strongest in the region 
of the 18S rRNA central pseudoknot, a highly conserved structural unit that forms the core of 
the small ribosomal subunit. Additional crosslinking was observed close to site A1 and in the 
5’-ETS pre-rRNA spacer region. Pseudoknot formation is guided by U3 and is required for 
A0, A1 and A2 cleavages (reviewed in (3)). Strikingly, Utp24 was recovered in association 
with the U3 snoRNA regions that base-pair with the pre-RNA as well as with the U3-binding 
sites in the 5’-ETS and the 18S elements forming the proximal and distal sides of the 
pseudoknot (see Figure 1H). These finding indicate a role for U3 in Utp24 recruitment to the 
A1 cleavage site and, potentially, a role for Utp24 in verification of U3-rRNA interactions. 
 Utp24 was also crosslinked to the eukaryotic expansion segment 6 (ES6) within the 18S 
rRNA central domain (Figure 1D). The ES6 region has recently emerged as a binding hub for 
many ribosome biogenesis factors including the RNA helicase Dhr1, which is required to 
dissociate U3 from the pre-rRNA following cleavages at sites A0 and A1, and preceding A2 
cleavage (35). Utp24 and Dhr1 both crosslink to the same U3 snoRNA regions, which 
engage in pre-rRNA interactions (35). It is possible that sequential binding of both proteins to 
U3 might be important to guide structural rearrangements to promote U3 release and/or 
positioning of Utp24 for A1 and A2 cleavages. 
 We did not detect clear Utp24 crosslinking around site A2 in the ITS1 sequence. We 
speculate that Utp24 is recruited to stable docking points within the mature 18S rRNA 
sequence, and only transiently interacts with the cleavage sites during catalysis. The 
observed coupling of cleavage at sites A1 and A2 suggests that they are brought into 
proximity by transient changes in pre-ribosome structure, which remain to be determined. 
 In vitro endonuclease assays revealed that recombinant Utp24 proteins from yeast and 
human each show activity on a pre-rRNA substrate containing yeast site A2 (Figure 2). As 
for other PIN domain proteins (7,25,30), this activity required Mn2+ ions and the conserved 
metal-binding amino acids of the PIN domain. Interestingly, yeast and human Utp24 not only 
cleaved the authentic site A2 (5’-AAC/ACAC-3’), but also at other positions in a similar 
sequence context (Figure 2). The cleavage pattern is identical in both proteins and therefore 
likely specific to the conserved Utp24 PIN domain. Very low levels of cleavage at these 
positions around site A2 are also observed in vivo (31), but they are underrepresented 
compared to the bona fide A2 site. Bound transacting factors within the SSU processome 
therefore likely assist the specificity of Utp24-mediated cleavage in vivo. The recently 
mapped 2a site in the human pre-rRNA (5’-C/GAC/GC-3) (19) appears to be very different to 
yeast A2. However, cleavage takes place at 5’C/purine3’ in both cases. We also tested RNA 
substrates including yeast site A1, but observed only low levels of cleavage in ACAC-rich 
regions within the 5’-ETS close to the U3 base-pairing sites (Figure S3B and data not 
shown). Notably, the sequence context of site A1 (5’-GU/UA-3’) does not match yeast A2 or 
human 2a, highlighting the importance of additional factors and/or structural arrangements 
within the pre-rRNA that might be needed to facilitate Utp24-mediated cleavage at this site in 
vivo. 
 Consistent with yeast data, in vivo studies on human UTP24 showed that an intact 
UTP24 PIN domain was required for cleavage at the 5’-end of 18S (site 1) and at site 2a 
within the ITS1 spacer, but not at A0 or A’ in the 5’-ETS (Figure 3). The requirement for 
UTP24 in site 1 cleavage and the presence of an alternative pathway to process to the 5’-
end of 18S in the absence of endonuclease cleavage by UTP24 was recently reported (15). 
However, in contrast to our results, XRN2 was not implicated in 5’-3’-exonuclease trimming 
to generate the aberrant 5’-end of 18S. This discrepancy might reflect the use of stable 
shRNA expression by Tomecki et al. (15), which strongly impaired cellular viability and could 
result in secondary effects. Notably, inspection of published northern analyses reveals 
phenotypes that link UTP24 to 2a cleavage (Figure S10 in (15)). 
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 Both Rcl1 and Utp24 have previously been proposed to cleave site A2 in yeast (4,5,9). A2 
cleavage can occur either co- or post-transcriptionally, so two separate enzymes might act in 
these distinct contexts. The catalytic role of yeast Rcl1 in A2 cleavage was reported to be 
dependent on an intact RDK motif, which was proposed to mediate RNA substrate binding 
(9). We found, however, that the Rcl1RDK mutation blocks binding to the SSU processome 
component Bms1 in vitro (Figure 5A), resulting in reduced nuclear import (Figure 5D) and 
the loss of stable incorporation into the processome (Figure 5B and 5C) in vivo. An intact 
SSU processome is required for A0-A2 cleavage potentially explaining the pre-rRNA 
processing defect in strains expressing Rcl1RDK. Mutation of the equivalent motif in human 
RCL1 (“RHK”) did not affect 18S production (Figure 4). However, human SSU processome 
assembly appears to differ from yeast, since RCL1 associates prior to A’ cleavage, while 
BMS1 largely binds after cleavage at A’ (36,37). 
 This work has implicated Utp24 as the endonuclease responsible for two coupled pre-
rRNA cleavages in 18S rRNA maturation. The enzymes responsible for cleavage at yeast 
and human site A0 and human A’ are probably also among the known SSU processome 
components, but their identities remain an intriguing mystery. 
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FIGURE LEGENDS 
Figure 1: RNA crosslinking sites of yeast Utp24 on (pre-)rRNA and the U3 snoRNA 
Illumina sequencing of cDNA libraries generated from crosslinked and subsequently trimmed 
RNAs recovered with purified Utp24 protein. Normalized data is plotted as reads per million 
mapped sequences. 
A Transcriptome-wide binding profiles. Data of two replicate experiments was mapped to the 
yeast genome using Novoalign. A total of 979330 mapped reads were recovered for dataset 
Utp24#1 and 1383819 for dataset Utp24#4, respectively. Pie charts illustrate the proportion 
of all sequences mapped to functional RNA classes (indicated on the right). 
B Sequences from datasets Utp24#1 and Utp24#4 and a control experiment with a non-
tagged strain (no tag) were aligned with the rDNA (RDN37-1) encoding the 35S pre-rRNA. 
The frequency of recovery is plotted as hits (total reads) for each individual nucleotide. 
C, E, G RNA binding profiles on the 18S rRNA (C), the 5’-external transcribed spacer (5’-
ETS) (E) and the U3 snoRNA (G). Hits (upper panels): total reads; dels (lower panels): 
mutations and microdeletions representing precise binding sites. Microdeletion peaks in the 
(pre-)rRNA (1-6, blue) and the U3 snoRNA (a-c, red) are labeled. The position of the mature 
18S, 5.8S, and 25S rRNAs (B, C, E) or the U3 snoRNA (G) are indicated by thick lines. 
D Predicted secondary structure of the mature 18S rRNA in S. cerevisiae. Utp24 crosslinking 
sites are marked on the sequence and shades indicate peak height with the highest peak 
shown in dark grey. Microdeletion peaks (see panel C) are highlighted by shaded blue 
circles. Binding sites for snoRNAs U3 around the central pseudoknot (red) and snR30 in the 
ES6 region (grey) are also indicated. 
F The distribution of hits mapping to crosslinked snoRNAs is plotted. 
H Schematic representation of base-pairing interactions between the pre-rRNA (black) and 
the U3 snoRNA (red) during pseudoknot formation. The approximate positions of Utp24 
microdeletion peaks are indicated in blue (1-6, pre-rRNA, see panels C and E) or red (a-c, 
U3 snoRNA, see panel G). 
Figure 2: Yeast and human recombinant Utp24 proteins cleave at yeast site A2 in vitro 
A Schematic of the RNA substrate mimicking a pre-rRNA fragment before A2 cleavage 
(yeast 35S: nt2301-2844) 
B In vitro transcribed RNA was incubated without recombinant protein, wild type or mutant 
Utp24, wild type Rcl1 or wild type or mutant UTP24 in the presence of 5 mM Mn2+ and 
analyzed by primer extension. The position of the primer is shown in panel A. Non-treated 
RNA substrate was used to generate a sequencing ladder and endogenous cleavage at site 
A2 in yeast total RNA is indicated. Recombinant Utp24-mediated cleavages at site A2 and 
5’C/A3’ sequences are marked by an arrow and asterisks, respectively. 
Figure 3: An intact UTP24 PIN domain is required for efficient site 1 and 2a cleavages 
in the human pre-ribosomal RNA 
A Key steps in human ribosome biogenesis. RNA intermediates of the minor, 2a-dependent 
pathway accumulating in the absence of XRN2 are shown in red. Radiolabeled probes used 
for primer extension (h1-RT; orange) or northern blotting (h18SE; purple and hITS1; green) 
are marked above the 47S precursor. ETS: external transcribed spacer; ITS: internal 
transcribed spacer. 
B HEK293 cells were stably transfected with plasmids expressing the FLAG tag (pcDNA5) or 
wild type (WT) or mutant forms of FLAG-UTP24 (D72N, D72N/D142N). RNA from control 
cells (GL2) or those depleted of endogenous UTP24 (UTP24) by RNAi, was analyzed by 
northern blotting using probes hybridizing to the 5’-end of ITS1 (h18SE, purple rectangle) or 
downstream of 2a (hITS1, green rectangle). Pre-rRNAs were detected using a 
PhosphorImager and total rRNA (28S/18S) was visualized by ethidium bromide staining. 
RNA species are marked on the right. 
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C RNA extracted from HEK293 cell lines as in panel B, but depleted of XRN2 alone (XRN2) 
or XRN2 and UTP24 (X+24) were analyzed as in B. 
D RNA levels from panel C were normalized to the 47S/45S pre-rRNAs and plotted for each 
XRN2-UTP24 double knockdown (black) and the single XRN2 knockdown (grey). The 
identity of each peak is indicated. Red: RNA species accumulating in the absence of XRN2. 
E RNA extracted from HEK293 cell expressing the FLAG-UTP24 D72N mutant, either 
treated with control siRNA (GL2) or depleted of UTP24 (UTP24), XRN2 (XRN2) or both 
(X+24), was analyzed by primer extension using probe h1-RT (panel A). Total RNA from 
control cells (GL2) expressing the FLAG tag alone (pcDNA5) was used to generate a 
sequencing ladder. Positions of the natural site 1 and 2 nt downstream are indicated on the 
left. 
Figure 4: An intact RCL1 RHK domain is not required for human 18S production 
A HEK293 cells were stably transfected with plasmids expressing the FLAG tag alone 
(pcDNA5) or wild type FLAG-RCL1 (WT) or the FLAG-RCL1-RHK mutant (RHK). The FLAG-
RCL1 mRNAs were rendered resistant to the RCL1 siRNA. RNA was extracted from control 
cells (GL2), or those depleted of endogenous RCL1 (RCL1) by RNAi and analyzed by 
northern blotting using a probe hybridizing to the 5’-end of ITS1 (h18SE, purple rectangle) or 
downstream of site 2a (hITS1, green rectangle). 
B RNA extracted from cells as listed in panel A, but depleted of XRN2 alone (XRN2) or 
XRN2 and RCL1 (X+R), was analyzed as in A. 
C The levels of the pre-rRNA intermediates from panel B were normalized to the 47S/45S 
precursors and plotted for each XRN2-RCL1 double knockdown (black) and the single XRN2 
knockdown (grey). The identity of each peak is indicated. RNA intermediates accumulating in 
the absence of XRN2 are shown in red. Asterisk: non-specific signal. 
Figure 5: The yeast Rcl1-RDK mutant fails to interact with Bms1 in vitro and interferes 
with SSU processome integration and nucleolar localization in vivo. 
A Recombinant GST-tagged Bms1(aa1-705) and GST were coupled to glutathione sepharose 
and incubated with wild type and mutant Rcl1 generated by in vitro translation in the 
presence of [35S] methionine. Bound material was eluted under denaturing conditions, 
separated by SDS-PAGE and analyzed by autoradiography. 10 % of the input and unbound 
material is also loaded. 
B and C Rcl1-containing complexes were purified on IgG sepharose and eluted by TEV 
protease cleavage. Co-purifying proteins were analyzed by SDS-PAGE and immunoblotting 
using antibodies against the C-terminus of the Rcl1-HTP tag after TEV cleavage (anti-TAP), 
the box C/D snoRNP component Nop1, or Mtr4 as a control. 2.5 % of the input material is 
also loaded (B). Co-purified RNA was extracted and analyzed by northern blotting using a 
probe hybridizing to the U3 snoRNA or two regions within the pre-rRNA (yA2-A3, green 
rectangle or yD-A2, purple rectangle; see Figure S1A for location of the probes). Mature 
18S and 25S rRNAs were visualized by ethidium bromide staining. 1% of the input material 
is also loaded. 
D Yeast strains expressing plasmid-encoded HTP-tagged wild type Rcl1 (top row) or the 
Rcl1-RDK mutant (middle row) were harvested and processed for immunofluorescence 
miscroscopy using the anti-TAP antibody. Lower row: Cells stained with an antibody against 
endogenous Nop1 as a nucleolar marker. From left to right: Immunofluorescence signal 
(red), DAPI (blue) and the merged image. 
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SUPPLEMENTARY TABLES 
 
 
Table S1:  Yeast strains used in these studies 
BY4741 MATa; his3∆1; leu2∆0; met15∆0; ura3∆0 (Euroscarf) 
Utp24-HTP MATa; his3∆1; leu2∆0; met15∆0; ura3∆0; UTP24-HTP-URA3 (this study) 
Rcl1-HTP MATa; his3∆1; leu2∆0; met15∆0; ura3∆0; RCL1-HTP-URA3 (this study) 
Gal::rcl1 MATa; his3∆1; leu2∆0; met15∆0; ura3∆0, KAN::-pGAL1-3HA::rcl1 (this study) 
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Table S2:  Oligonucleotides (5’-3’) used in these studies 
Strain construction  
Utp24-HTP  
F  GGCGGTCACGCATACGTCATTGAAAAATTGCCAGATGTCTTTGAG
CACCATCACCATCACC 
R  CCAAAAACATTGCACTACATACTTAAAGAGTGAATACACAGTAGTT
ACGACTCACTATAGGG 
Rcl1-HTP  
F  CAAGGGTATTGGTTTCACAAACACAAGCAAAAAGATTGCAGAGCA
CCATCACCATCACC 
R  ATACAGTGGTCTAATATCTATTGAATAATATTAGAACATGTACGAC
TCACTATAGGG 
GAL1-3HA::rcl1  
GAL/HA-F4 CATAAGCTACGTATGTTGTAAGGGTATAACATCTGTCAAGGAATTC
GAGCTCGTTTAAAC 
GAL/HA-R3 ACCCTTGGAAAGTGGTGTATTTGGGGGCGGAAGATGACATGCAC
TGAGCAGCGTAATCTG 
CRAC  
3’-Linker 5’- rAppTGGAATTCTCGGGTGCCAAGG/ddC/ -3’ 
(miRCat-33TM) 
5'-Linker (L5Ab) 5’-invddT-ACACrGrArCrGrCrUrCrUrUrCrCrGrArUrCrU 
rNrNrNrArUrUrArGrC-OH-3’ 
RT CCTTGGCACCCGAGAATT (miRCat-33™) 
PCR - F AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGAC
GCTCTTCCGATCT 
PCR - R CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGGCC
TTGGCACCCGAGAATTCC 
Cloning  (Vector) 
Human  
UTP24  (pcDNA5 and pGEX-6P1) 
F (Bgl ll) CACCAGATCTATGGGGAAGCAAAAGAAAACAAGGAAGTATGCGA
CCATGAAGCGAATGCTTAG  
R (Xho I) CGCGCTCGAGTTAGAATCGAGGGGCTCCATAATCATCTGG 
RCL1  (pcDNA5) 
F (BamH I) CACCGGATCCATGGCGACTCAGGCGCACTC 
R (Xho I) CCCCCTCGAGTCACTTGAGGGTCTTGCTAAGGTTGG 
  
Yeast  
Bms1  (pGEX-6P1) 
F (BamH I) CACCGGATCCATGGAGCAGTCTAATAAACAGCACCGTAAG 
R (Sal I) GTCGACTTACCTCCTCATCTTACGTGGACGAGATTC 
Rcl1  (pET100 and pGEX-6P1) 
F (BamH I) CACCGGATCCATGTCATCTTCCGCCCCCAAATAC 
R (Sal I) GTCGACCTATGCAATCTTTTTGCTTGTGTTTGTG 
Rcl1-HTP  (pRS316) 
F (Sal I) AGCTGTCGACCGAAACATAAAGCTGAAAGACTAG 
R (Sal I) ACGTAGTCGACGCTGGATGGGAAGCGTACC 
Utp24  (pGEX-6P1) 
F (BamH I) GCGCGGATCCATGGGTAAAGCTAAGAAAACAAGAAAGTTTG 
R (Sal I) CCCCGTCGACTTAAAAGACATCTGGCAATTTTTCAATG 
Nob1 (pGEX-6P1) 
F (Bgl II) CACCAGATCTATGACCGAAAACCAAACCGCAC 
R (Xho I) CTCGAGCTAACTTCTCCTTTTGGAACTGTTGACGTAC 
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Mutagenesis  (Mutation) 
Human  
UTP24  D72N 
F  CCACCTTACCACATCCTCGTTAATACCAACTTTATCAACTTTTCC 
R  GGAAAAGTTGATAAAGTTGGTATTAACGAGGATGTGGTAAGGTGG 
UTP24  D142N 
F  CCATGTACACACAAAGGAACCTATGCAAATGACTGCTTAGTACAG
AGAGTAAC 
R  GTTACTCTCTGTACTAAGCAGTCATTTGCATAGGTTCCTTTGTGTG
TACATGG 
RCL1 RHK -> AAA 
F  CGATAGAATTTTTGGCGGCTTTGGCGAGCTTTTTCCAG 
R  CTGGAAAAAGCTCGCCAAAGCCGCCAAAAATTCTATCG 
  
Yeast  
Bms1  aa705 -> stop 
F  GATAATTCATTCACTAATTTTGATGCGGAGTAAAAAAAGGACTTAA
CCATG 
R  CATGGTTAAGTCCTTTTTTTACTCCGCATCAAAATTAGTGAATGAA
TTATC 
Rcl1 RDK -> AAA 
F  GACGAAAGATTCATAATCCTCTTGGCAGCTATTGCGAAGATCTTTA
ATACTGAAGTC 
R  GACTTCAGTATTAAAGATCTTCGCAATAGCTGCCAAGAGGATTAT
GAATCTTTCGTC 
Utp24 D68N 
F  CAATCAAGCTATAAAGCCACCTTATCAAGTACTGATAAATACCAAT
TTTATAAATTTTTCTATCC 
R GGATAGAAAAATTTATAAAATTGGTATTTATCAGTACTTGATAAGG
TGGCTTTATAGCTTGATTG 
Utp24 D138N 
F  CGCACAAGGGTACGTACGCGAATGACTGTTTAGTGCATCGAGTC 
R  GACTCGATGCACTAAACAGTCATTCGCGTACGTACCCTTGTGCG 
Northern blotting  
hITS1 (6121) AGGGGTCTTTAAACCTCCGCGCCGGAACGCGCTAGGTAC 
h18SE  CCTCGCCCTCCGGGCTCCGTTAATGATC 
yU3 (snR17a)  ATGGGACTCATCAACCAAGTTGG 
yD-A2 CGGTTTTAATTGTCCTA 
yA2-A3 TGTTACCTCTGGGCCCCGATTG 
Primer extension  
h1-RT  CACTGTACCGGCCGTGCG 
yA1-RT TGAGCCATTCGCAGTTTCAC 
yA2-RT GTTTGTTACCTCTGGGCCCC 
yD-RT CCATCTCTTGTCTTCTTGCCCAG 
For transcription  
 (yeast 35S pre-rRNA: nt2301-2844) 
y18S-200-T7-F  CGGAATTCTAATACGACTCACTATAGGGCTTGCGTTGATTACGTC
CC   (T7 promotor) 
yITS1-R CCAGTTACGAAAATTCTTGTTTTTGAC 
 (yeast 35S pre-rRNA: nt335-1846) 
y35S-nt335-T7F CGGAATTCTAATACGACTCACTATAGGGAATGCCTTGTTGAATAG
CC   (T7 promotor) 
y35S-nt1846-R CAATTCCTTTAAGTTTCAGCCTTG 
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Table S3:  siRNAs used in these studies 
Gene Target Sequence (5’-3’)  Source 
Luciferase GL2  CGUACGCGGAAUACUUCGA Eurofins MWG (1) 
RCL1 GAACAUGACUGUAGCGUCC Eurofins MWG 
UTP24 UCCAAGAUUUGAACGAUUA Eurofins MWG 
XRN2 AAGAGUACAGAUGAUCAUG Eurofins MWG 
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Table S4:  Antibodies used in these studies 
Target   Source Cat. No. Dilution Species 
Western blotting     
α-hKaryopherin  Santa Cruz sc-11367 1:1000 rabbit 
α-hRCL1 Eurogentec (2)  custom 1:250 rabbit 
α-hUTP24 Eurogentec (2)  custom 1:1000 rabbit 
α-hXRN2 Bethyl Laboratories, Inc. A301-103A 1: 2000 rabbit 
α-TAP* Thermo Scientific CAB1001 1:10,000  rabbit 
α-yNop1 Santa Cruz sc-57940 1:2000 mouse 
α-yMtr4 Eurogentec custom 1:10,000 rabbit 
α-mouse-HRP  Santa Cruz sc-2316 1:10,000 donkey 
α-rabbit-HRP  Santa Cruz sc-2313 1:10,000 donkey 
Immunofluorescence     
α-TAP Thermo Scientific CAB1001 1:1000 rabbit 
α-yNop1 Santa Cruz sc-57940 1:2000 mouse 
α-rabbit-IgG 
(Alexa Fluor 555 
conjugate) 
Invitrogen A-31572 1:500 donkey 
α-mouse-IgG 
(Alexa Fluor 555 
conjugate) 
Invitrogen A-31570 1:500 donkey 
 
* The α-TAP antibody recognizes the C-terminus of the HTP construct before and after TEV 
cleavage. 
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SUPPLEMENTARY FIGURE LEGENDS 
Figure S1: Ribosome biogenesis pathways in yeast and humans 
A, B Key steps in the pre-ribosomal RNA processing pathways in S. cerevisiae (A) and H. 
sapiens (B). Cleavages important for 18S rRNA processing are indicated. RNA 
intermediates of the minor, 2a-dependent human pathway that are accumulating in the 
absence of XRN2 (30SL5’, 36S and the ITS2 fragment) are highlighted in red. The positions 
of radiolabeled probes used for primer extension (yA1-RT, yD-RT, yA2-RT and h1-RT) or 
northern blotting (yD-A2, yA2-A3, h18SE and hITS1) are marked above the primary 
transcripts. ETS: external transcribed spacer; ITS: internal transcribed spacer. 
Figure S2: In vivo RNA-protein crosslinking studies (CRAC) to define binding sites for 
Utp24 and Rcl1 
A Outline of the CRAC crosslinking technique. 
B Proteins purified from UV-crosslinked yeast strains expressing either C-terminally HTP-
tagged Utp24 or Rcl1 were separated by SDS-PAGE and visualized by immunoblotting 
using the anti-TAP antibody (left panel), which recognizes the C-terminus of the HTP 
construct after TEV cleavage. Radioactively labeled crosslinked RNA fragments were 
detected by autoradiography (right panel). 
C Mutations and microdeletions on the 5’-end of the 18S rRNA (nucleotides 1-20), 
representing precise Utp24 binding sites from two replicate experiments, are plotted as 
deletions per million mapped sequences. The position of the mature 18S rRNA and site A1 
are indicated on the left. 
Figure S3: Recombinant yeast Utp24 and Nob1 exhibit specific in vitro cleavage 
activities in the presence of 5 mM Mn2+ at sites A2 and D, respectively. 
A Recombinant, GST-tagged wild type or mutant yeast Utp24, wild type yeast Rcl1 or wild 
type and mutant human UTP24 proteins were expressed in E. coli and purified on a 
glutathione sepharose column in the presence of 1 mM Mn2+. The N-terminal GST tag was 
removed by prescission protease (PP) cleavage and the proteins separated by SDS-PAGE 
and stained with Coomassie blue. Asterisk: free GST-tag. 
B In vitro transcribed RNA mimicking a 5’-ETS-18S pre-rRNA fragment before A0 and A1 
cleavage (yeast 35S pre-rRNA: nt335-1846) was incubated without recombinant protein, wild 
type or mutant yeast Utp24 protein in the presence of 5 mM Mn2+ and analyzed by primer 
extension. The position of the primer (yA1-RT) is shown. Non-treated RNA substrate was 
used to generate a sequencing ladder. Recombinant Utp24-mediated cleavages in the 5’-
ETS are marked by asterisks. 
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C Recombinant, GST-tagged wild type yeast Nob1 was expressed in E. coli, purified on a 
glutathione sepharose column in the absence of Mn2+ and analyzed by SDS-PAGE and 
Coomassie staining. Uncleaved, GST-tagged yNob1 protein was used in the cleavage 
assays shown in panel D. 
D In vitro transcribed RNA mimicking a pre-rRNA fragment before A2 and D site cleavage 
(yeast 35S pre-rRNA: nt2301-2844) was incubated without recombinant protein, wild type or 
mutant yeast Utp24 or wild-type Nob1 protein in the presence of 5 mM Mn2+ and analyzed by 
primer extension. The positions of the primers yA2-RT (left) and yD-RT (right) are shown. 
Non-treated RNA substrate was used to generate a sequencing ladder. Recombinant 
protein-mediated cleavages at and around sites A2 and D are marked by arrows and 
asterisks, respectively. 
Figure S4: Wild type and mutant recombinant proteins exhibit in vitro cleavage 
activity at site A2 in the presence of 10 mM Mg2+ 
A Recombinant wild type or mutant yeast Utp24 and wild type yeast Rcl1 proteins as in 
Figure S3A were dialyzed into buffer MKG (50 mM MOPS/KOH pH 7.5, 200 mM KCl, 10 % 
glycerol, 1 mM DTT, 1 mM THP), and analyzed by SDS-PAGE and Coomassie staining. 
B Equal amounts of wild type or mutant yeast Utp24 or wild-type Rcl1 proteins in buffer MKG 
(see panel A), or no protein, were incubated for 1h at 30°C with in vitro transcribed RNA 
mimicking a pre-rRNA fragment before A2 cleavage (yeast 35S pre-rRNA: nt2301-2844). 
Here, reactions were carried out in the presence of 10 mM Mg2+ in 50 mM MOPS/KOH pH 
7.5, 100 mM KCl, 2 mM dithiothreitol, 100 μg ml-1 bovine serum albumin, 0.8 unit μl-1 
RNasin, 5% glycerol and 10 ng µl-1 E.coli tRNA. 10 μl reactions containing ~20 pmol of 
protein were pre-incubated for 20 min at 30°C before adding 0.125 pmole of the RNA 
substrate, which was then analyzed by primer extension using primer yA2-RT. Recombinant 
protein-mediated cleavages at site A2 are marked by an arrow. 
Figure S5: Protein and RNA analysis of UTP24 RNAi-rescue cell lines 
A HEK293 cells as in Figure 3 were stably transfected with plasmids expressing the FLAG 
tag alone (pcDNA5) or wild type (WT) or mutant forms of FLAG-UTP24 (D72N, 
D72N/D142N). The FLAG-UTP24 cDNA sequence had been modified to render the mRNA 
resistant to the UTP24 siRNA. Protein extracted from control cells (GL2), or those depleted 
of endogenous UTP24 (UTP24), XRN2 (XRN2) or both (X+24) by RNAi, was separated by 
SDS-PAGE and transferred to nitrocellulose membrane. Protein levels were analyzed by 
immunoblotting using antibodies specific for UTP24 and XRN2, or Karyopherin as loading 
control. The asterisk denotes a non-specific protein recognized by the antibody. 
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B RNA levels from Figure 3B were normalized to the 47S/45S pre-rRNAs and plotted for 
each GL2 (grey) or UTP24 (black) knockdown. The identity of each peak is indicated. 
C RNA extracted from HEK293 cell as in panel A was analyzed by primer extension using a 
probe to detect the 5’-end of 18S (h1-RT). Total RNA from cells expressing the FLAG tag 
alone (pcDNA5), treated with the control siRNA GL2, was used to generate a sequencing 
ladder. Positions of the natural site 1 and 2 nt downstream are indicated on the left. 
Figure S6: Protein analysis of RCL1 RNAi-rescue cell lines 
A HEK293 cells as in Figure 4 were stably transfected with plasmids expressing the FLAG 
tag alone (pcDNA5) or wild type FLAG-RCL1 (WT) or the FLAG-RCL1-RHK mutant (RHK). 
The FLAG-RCL1 mRNAs were rendered resistant to the RCL1 siRNA. Protein extracted 
from control cells (GL2), or those depleted of endogenous RCL1 (RCL1), XRN2 (XRN2) or 
both (X+R) by RNAi were analyzed by immunoblotting using antibodies specific for RCL1 
and XRN2, or Karyopherin as loading control. The asterisk denotes a non-specific protein 
recognized by the antibody. 
B RNA levels from Figure 4A were normalized to the 47S/45S pre-rRNAs and plotted for 
each GL2 (grey) or RCL1 (black) knockdown. The identity of each peak is indicated. 
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